Short description
Bioheng is a high-tech R&D innovation company.
Description
BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed and automated production system in compliance with regulatory guidelines.
In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via integrating resources from both parties. Bioheng is dedicated to develop safer, effective and less expensive cell therapy drugs to benefit more patients.
Last funding
No Way
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Nanjing, Jiangsu, China, Asia
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$34056 - 789030
Sign in for full access
Investors
Blurry Noaccess, No Way, Nopepepe, Cannot Access, Cannot Access, Noway Youcantaccess
Sign in for full access
Founders
Xiaohong He